Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
The Lancet. Respiratory Medicine
|
December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
Ganesh Raghu, Kevin K Brown, Harold R Collard, et al.
Annals of the American Thoracic Society
|
March 1, 2023
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report
Guang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report
Daniel Couriel, Paul A Carpenter, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 1, 2006
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report
Steven Z Pavletic, Paul Martin, Stephanie J Lee, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
The Lancet. Respiratory Medicine
|
December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
Ganesh Raghu, Kevin K Brown, Harold R Collard, et al.
Annals of the American Thoracic Society
|
March 1, 2023
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report
Guang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report
Daniel Couriel, Paul A Carpenter, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 1, 2006
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report
Steven Z Pavletic, Paul Martin, Stephanie J Lee, et al.
Page
of 8